RARB and lung cancer: Retinoic acid receptor β is believed to promote transcription of tumor suppressor genes and has been found to be decreased in many preneoplastic lung cancers [7, 8]; therefore, decreased expression of RARβ has been suggested as a biomarker for lung cancer risk.